37 results
10-K
2022 FY
EX-10.20
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
of this Agreement, and (ii) none of the survival periods or limitations contained in this Section 8 shall apply to any claims relating to fraud or intentional … not be applicable to claims for fraud or intentional misrepresentation.
(d)Indemnification Procedures.
(i)Notice of Claim. An Indemnified Party may assert
10-K
2022 FY
EX-31.1
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
may set;
If we are unable to comply, or have not fully complied, with applicable federal and state healthcare fraud and abuse laws, false claims laws … “fraud and abuse,” including anti-kickback laws and false claims laws. Anti-kickback laws including, without limitation, the federal Anti-Kickback
6-K
EX-99.3
38qib cmm44bf35r7btw
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K/A
EX-99.2
xwpf4502i
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
jggrp yap
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-1.1
3aapjn8k6vdhlf1yu
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
57c79viqcuu0mr06tm
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am